In addition, we observed that CX4945 plus anti‐PD‐1 therapy significantly enhanced the expression of IFN‐γ in adoptive CD8+ T cells in tumor tissues compared with anti‐PD‐1 monotherapy (Figure 5H,I). This evidence concerns the gene CD8A and neoplasm.